-
Heat Biologics Rallies On Provisional Coronavirus Patent Application
Monday, March 2, 2020 - 12:11pm | 285Read More...Heat Biologics Inc (NASDAQ: HTBX) shares were trading more than 50% higher Monday after the Durham, North, Carolina-based biopharma company said in an SEC filing that it has filed a provisional patent application that would apply its immune system activating technology for the treatment or...
-
Biogen Rallies On Tecfidera Patent Decision
Wednesday, February 5, 2020 - 3:18pm | 172Read More...Biogen Inc (NASDAQ: BIIB) shares were trading higher Wednesday following the issuing of a decision by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board on a patent trial challenge by Mylan NV (NASDAQ: MYL) on '514 Tecfidera that was in Biogen's favor....
-
IBM Gets Patent For A 'Self-Aware Token' That Tracks Its Own 'Life Cycle' Even When Offline
Wednesday, January 29, 2020 - 3:50am | 566Read More...The International Business Machines Corporation (NYSE: IBM), or IBM, has received a patent for a so-called "self-aware token" that tracks its complete life cycle even during offline transactions. What Happened The United States Patent and Trademark Office awarded the patent to IBM on...
-
China's Largest Insurer Blockchain Subsidiary Files For US IPO
Thursday, November 14, 2019 - 8:20am | 348Read More...OneConnect Financial Technology Ltd, a subsidiary of China’s largest insurer Ping An Insurance (Group) Co of China Ltd (OTC: PNGAY), filed for an initial public offering with the U.S. Securities and Exchange Commission on Wednesday. What Happened The fintech company is aiming to...
-
Aclaris Shares Trade Higher On Patent Win For Facial Redness Drug
Tuesday, July 9, 2019 - 10:33am | 318Read More...Aclaris Therapeutics Inc (NASDAQ: ACRS) shares were seeing some upward momentum Tuesday on the back of the announcement of a patent win. What Happened The U.S. Patent and Trademark Office has granted the company a patent — No. 10,335,391 — covering the methods to treat facial...
-
Bank Of America: Apple Is Still An Innovator
Friday, May 17, 2019 - 12:49pm | 454Read More...Apple Inc. (NASDAQ: AAPL) was granted 2,160 patents throughout 2018, suggesting the company's era of innovation is far from "dead," according to Bank of America Merrill Lynch. The Analyst Wamsi Mohan maintained a Buy rating on Apple with an unchanged $230 price target...
-
Vireo Health International Receives Patent For Tobacco With Cannabinoid Additives
Thursday, April 25, 2019 - 4:09pm | 359Read More...Vireo Health International (OTC: VREOF) said Thursday that the United States Patent and Trademark Office has issued a Notice of Allowance for its patent application for less-harmful tobacco products infused with cannabinoids. What Happened The patent is titled "Tobacco Products with...
-
Groupon, IBM Settle Patent Lawsuits In $57M Deal
Monday, October 1, 2018 - 1:42pm | 359Read More...Shares of Groupon Inc (NASDAQ: GRPN) gained more than 3 percent Monday after the mobile and online marketplace company reached a settlement in patent litigation with IBM (NYSE: IBM) and struck a new patent cross-license agreement with Big Blue. What Happened Groupon was accused by...
-
Baird: RPX Corp. Buyout Would Be An 'Incremental Positive'
Wednesday, December 13, 2017 - 2:38pm | 421Read More...Patent risk management services company RPX Corp (NASDAQ: RPXC) has long been rumored to be a takeover target. In March, the company was reportedly approached by private equity firms regarding a potential buyout. Recent M&A speculation surrounding the company led to comments on the rumor...
-
Eli Lilly Shares Spike On Patent Victory
Thursday, October 5, 2017 - 5:07pm | 350Read More...The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co (NYSE: LLY) Thursday in an inter partes review of the ’209 patent for Alimta, a chemotherapy drug for lung cancer. “Based on the record before us, we conclude that petitioner has failed to demonstrate by a...
-
Patent Application Sends Cesca Therapeutics Shares Soaring
Tuesday, October 3, 2017 - 1:29pm | 396Read More...Cesca Therapeutics Inc (NASDAQ: KOOL) shares have moved out of a one-year trading range of $2.50–$4 Tuesday and are currently at their highest level in over a year. The catalyst being an announcement from the company that the U.S. Patent and Trademark Office issuing a notice of allowance...
-
Digital Ally Wins Critical PTO Ruling In Patent Lawsuit With Axon
Friday, July 7, 2017 - 9:00am | 516Read More...Digital Ally, Inc. (NASDAQ: DGLY) shares popped as much as 79 percent in Friday’s pre-market session after the company reported “significant victory” in its legal battle with Axon Enterprise Inc (NASDAQ: AAXN). The U.S. Patent and Trademark Office (PTO) denied Axon’s...
-
Patent Wars Surprisingly Reach The Cannabis Industry: How Do You Register A Plant?
Thursday, May 18, 2017 - 11:44am | 584Read More...New Frontier Data, one of the leading analytics firms in the cannabis industry, recently published a 400-page research note titled "The Cannabis Industry Annual Report" looking at the state of legal marijuana markets for 2017. The extensive document goes into a wide array of topics, from...
-
Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy
Thursday, April 6, 2017 - 1:08pm | 365Read More...Argus' Stephen Biggar initiated coverage of Sanofi SA (ADR) (NYSE: SNY) with a Buy rating and $50 price target as the company has moved past a challenging period. According to Biggar, Sanofi has suffered through a period in which two of its best selling drugs, Lantus (diabetes) and Plavix (...
-
Your Guide To Patent Play Exposure
Saturday, March 11, 2017 - 8:34pm | 751Read More...Litigations more often trigger strong stock moves, and this was evident in the rally by the shares of ParkerVision, Inc. (NASDAQ: PRKR) last Wednesday. ParkerVision Goes 4 Up Over Qualcomm ParkerVision announced on Wedneday that the Patent Trial and Appeal Board's latest decisions with respect...
